Schizophrenia and bipolar disorder are severe mental disorders that often manifest in early adulthood. Effective treatments ...

The following is a summary of “Spaced Transcranial Direct Current Stimulation for Major Depression,” published in the January ...

Groundbreaking research shows psilocybin therapy equals traditional antidepressants in treating depression with potential ...

Project Unloaded's report, Triggering, outlines strategies to improve mental health, prevent suicides, and enhance community safety concerning gun issues.

Depression speeds up physical illness. A study shows adults with depression develop conditions 30% faster. Read more.

After SPN-820's failure, Supernus is relying on its non-stimulant ADHD drug Qelbree and the recently approved Parkinson’s ...

Supernus Pharmaceutical’s stock declined following the release of disappointing Phase IIb trial results for SPN-820, an ...

Researchers identify predictive markers of response to immunotherapy treatment in a study involving data from over 700 patients across six different cohorts. The study has significant relevance, ...

Supernus' SPN-820 Phase 2b study in treatment-resistant depression failed to meet its primary endpoint, prompting further ...

One-year follow-up data demonstrates sustained improvements across venous specific quality-of-life (QoL) indicators.

If you struggle with ED, you’re not alone — data suggests this medical condition affects around 30 million men in the U.S. And while there are many causes of ED, you may share one problem that’s ...

Supernus Pharmaceuticals may have had a potential path forward for its depression drug candidate cut off after the asset ...